0001225208-14-015767.txt : 20140630 0001225208-14-015767.hdr.sgml : 20140630 20140630162322 ACCESSION NUMBER: 0001225208-14-015767 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140627 FILED AS OF DATE: 20140630 DATE AS OF CHANGE: 20140630 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co. Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MERCK DRIVE STREET 2: P.O. BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 BUSINESS PHONE: 908-423-1000 MAIL ADDRESS: STREET 1: ONE MERCK DRIVE STREET 2: P.O. BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Deese Willie A CENTRAL INDEX KEY: 0001328766 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 14949248 MAIL ADDRESS: STREET 1: MERCK & CO INC ONE MERCK DRIVE STREET 2: P O BOX 100 CITY: WHITEHOUSE STATION STATE: NJ ZIP: 08889-0100 4 1 doc4.xml X0306 4 2014-06-27 0000310158 Merck & Co. Inc. MRK 0001328766 Deese Willie A ONE MERCK DRIVE WHITEHOUSE STATION NJ 08889-0100 1 Exe V-P & Pres. MMD Common Stock 2014-06-27 4 M 0 42956.0000 23.4500 A 149178.3873 D Common Stock 2014-06-27 4 M 0 22108.0000 35.0900 A 171286.3873 D Common Stock 2014-06-27 4 M 0 7226.0000 31.8400 A 178512.3873 D Common Stock 2014-06-27 4 S 0 72290.0000 58.2550 D 106222.3873 D Common Stock - 401(k) Plan 679.9051 I By 401(k) Stock Option (right to buy) 31.8400 2014-06-27 4 M 0 7226.0000 0.0000 D 2006-02-25 2015-02-24 Common Stock 7226.0000 0.0000 D Stock Option (right to buy) 35.0900 2014-06-27 4 M 0 22108.0000 0.0000 D 2007-03-03 2016-03-02 Common Stock 22108.0000 0.0000 D Stock Option (right to buy) 23.4500 2014-06-27 4 M 0 42956.0000 0.0000 D 2010-04-24 2019-04-23 Common Stock 42956.0000 0.0000 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.9600 to $58.5200, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote. Holdings include shares acquired in dividend reinvestment transactions. Includes shares acquired and dividends earned through April 7, 2014, in the Merck U.S. Savings Plan, a 401(k) plan. Katie Fedosz as Attorney-in-Fact for Willie A. Deese 2014-06-30